Deep features to detect pulmonary abnormalities in chest X-rays due to infectious diseaseX: Covid-19, pneumonia, and tuberculosis.

Chest X-ray (CXR) imaging is a low-cost, easy-to-use imaging alternative that can be used to diagnose/screen pulmonary abnormalities due to infectious diseaseX: Covid-19, Pneumonia and Tuberculosis (TB). Not limited to binary decisions (with respect to healthy cases) that are reported in the state-of-the-art literature, we also consider non-healthy CXR screening using a lightweight deep neural network (DNN) with a reduced number of epochs and parameters. On three diverse publicly accessible and fully categorized datasets, for non-healthy versus healthy CXR screening, the proposed DNN produced the following accuracies: 99.87% on Covid-19 versus healthy, 99.55% on Pneumonia versus healthy, and 99.76% on TB versus healthy datasets. On the other hand, when considering non-healthy CXR screening, we received the following accuracies: 98.89% on Covid-19 versus Pneumonia, 98.99% on Covid-19 versus TB, and 100% on Pneumonia versus TB. To further precisely analyze how well the proposed DNN worked, we considered well-known DNNs such as ResNet50, ResNet152V2, MobileNetV2, and InceptionV3. Our results are comparable with the current state-of-the-art, and as the proposed CNN is light, it could potentially be used for mass screening in resource-constraint regions.

Detecting COVID-19 infection status from chest X-ray and CT scan via single transfer learning-driven approach.

COVID-19 has caused over 528 million infected cases and over 6.25 million deaths since its outbreak in 2019. The uncontrolled transmission of the SARS-CoV-2 virus has caused human suffering and the death of uncountable people. Despite the continuous effort by the researchers and laboratories, it has been difficult to develop reliable efficient and stable vaccines to fight against the rapidly evolving virus strains. Therefore, effectively preventing the transmission in the community and globally has remained an urgent task since its outbreak. To avoid the rapid spread of infection, we first need to identify the infected individuals and isolate them. Therefore, screening computed tomography (CT scan) and X-ray can better separate the COVID-19 infected patients from others. However, one of the main challenges is to accurately identify infection from a medical image. Even experienced radiologists often have failed to do it accurately. On the other hand, deep learning algorithms can tackle this task much easier, faster, and more accurately. In this research, we adopt the transfer learning method to identify the COVID-19 patients from normal individuals when there is an inadequacy of medical image data to save time by generating reliable results promptly. Furthermore, our model can perform both X-rays and CT scan. The experimental results found that the introduced model can achieve 99.59% accuracy for X-rays and 99.95% for CT scan images. In summary, the proposed method can effectively identify COVID-19 infected patients, could be a great way which will help to classify COVID-19 patients quickly and prevent the viral transmission in the community.

ACCU3RATE: A mobile health application rating scale based on user reviews.

BACKGROUND: Over the last decade, mobile health applications (mHealth App) have evolved exponentially to assess and support our health and well-being. OBJECTIVE: This paper presents an Artificial Intelligence (AI)-enabled mHealth app rating tool, called ACCU3RATE, which takes multidimensional measures such as user star rating, user review and features declared by the developer to generate the rating of an app. However, currently, there is very little conceptual understanding on how user reviews affect app rating from a multi-dimensional perspective. This study applies AI-based text mining technique to develop more comprehensive understanding of user feedback based on several important factors, determining the mHealth app ratings. METHOD: Based on the literature, six variables were identified that influence the mHealth app rating scale. These factors are user star rating, user text review, user interface (UI) design, functionality, security and privacy, and clinical approval. Natural Language Toolkit package is used for interpreting text and to identify the App users' sentiment. Additional considerations were accessibility, protection and privacy, UI design for people living with physical disability. Moreover, the details of clinical approval, if exists, were taken from the developer's statement. Finally, we fused all the inputs using fuzzy logic to calculate the new app rating score. RESULTS AND CONCLUSIONS: ACCU3RATE concentrates on heart related Apps found in the play store and App gallery. The findings indicate the efficacy of the proposed method as opposed to the current device scale. This study has implications for both App developers and consumers who are using mHealth Apps to monitor and track their health. The performance evaluation shows that the proposed mHealth scale has shown excellent reliability as well as internal consistency of the scale, and high inter-rater reliability index. It has also been noticed that the fuzzy based rating scale, as in ACCU3RATE, matches more closely to the rating performed by experts.